{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:28:34Z","timestamp":1790926114929,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.eplepsyres.2006.11.006","type":"journal-article","created":{"date-parts":[[2006,12,30]],"date-time":"2006-12-30T07:07:18Z","timestamp":1167462438000},"page":"284-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Dose\u2013response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures"],"prefix":"10.1016","volume":"73","author":[{"given":"Eric","family":"Snoeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armel","family":"Stockis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2006.11.006_bib1","series-title":"NONMEM User's Guide. NONMEM Project Group","year":"1992"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/seiz.2000.0380","article-title":"A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000mg daily and 4000mg daily, without titration in patients with refractory epilepsy","volume":"9","author":"Betts","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/01621459.1993.10594284","article-title":"Approximate inference in generalized linear mixed models","volume":"88","author":"Breslow","year":"1993","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1528-1157.2001.19400.x","article-title":"Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components","volume":"42","author":"Cramer","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/01621459.1996.10476708","article-title":"Physiological pharmacokinetic analysis using population modelling and informative prior distribution","volume":"91","author":"Gelman","year":"1996","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archneur.1985.04060050061009","article-title":"Mathematical models of patterns of seizures. Their use in the evaluation of drugs","volume":"42","author":"Hopkins","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs","volume":"301","author":"L\u00f6scher","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.313.7066.1169","article-title":"New antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"313","author":"Marson","year":"1996","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-1331.2006.01381.x","article-title":"Assessment of a dose-response relationship of levetiracetam","volume":"13","author":"Meencke","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(03)00049-3","article-title":"Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures","volume":"73","author":"Miller","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib16","series-title":"Handbook of Epilepsy Treatment","article-title":"Levetiracetam","author":"Shorvon","year":"2000"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2307\/2532086","article-title":"Some covariance models for longitudinal count data with overdispersion","volume":"46","author":"Thall","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib18","unstructured":"World Health Organization, 2004. WHO Drug Information. 18, p. 152. Available at http:\/\/www.who.int\/druginformation\/vol18num2-2004\/DI18-2.pdf."},{"key":"10.1016\/j.eplepsyres.2006.11.006_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011555016423","article-title":"Evaluating pharmacokinetic\/pharmacodynamic models using the posterior predictive check","volume":"28","author":"Yano","year":"2001","journal-title":"J. Pharmacokinet. Pharmacodyn."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121106004463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121106004463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:17:03Z","timestamp":1760275023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121106004463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0920121106004463"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2006.11.006","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose\u2013response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2006.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}